Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06544564 · ClinicalTrials.gov registry record · NA

Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population

A NA study of Venous Leg Ulcer, sponsored by BioLab Holdings.

Recruiting
Registry status
NA
Development phase
150
Enrollment target
9
Study locations

NCT06544564 is a NA study of Venous Leg Ulcer that is actively recruiting participants, run by BioLab Holdings. The registered enrollment target is 150 participants, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (38% lower). The trial reports 9 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06544564, a NA study of Venous Leg Ulcer, is actively recruiting participants, sponsored by BioLab Holdings.

RECRUITING
Registry status
NA
Development phase
150 participants
Enrollment target
9
Study locations

Study Summary

This study is designed to assess the clinical effectiveness of Membrane Wrap, a human amniotic membrane for the management of difficult to heal partial- or full-thickness venous leg ulcers (VLUs)

Conditions Studied

Interventions

  • OTHER Standard of Care
  • DEVICE Membrane Wrap™

Study Locations (9)

Florida

  • Midland Florida Clinical Research Center - DeLand
  • Biophase Research - North Miami Beach
  • Doctors Research Network - South Miami

Arizona

  • Tital Clinical Research - Mesa

California

  • Center for Clinical Research - San Francisco

Illinois

  • Gateway Clinical Trials - O'Fallon

New York

  • Northwell Health - Lake Success

Ohio

  • Kent State College of Podiatry - Cleveland

Texas

  • Advantage Foot Care of Houston - Houston

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2025-03-31
Est. Completion 2026-09-30
Phase NA

Sponsor

BioLab Holdings

4 total trials

What the Registry Record Tells You About NCT06544564

The ClinicalTrials.gov registry entry for NCT06544564 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (38% lower). The listed sponsor is BioLab Holdings, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT06544564 reports 9 study locations spanning 7 distinct geographic areas - top geographies include Florida, Arizona, California.

Frequently Asked Questions

What is clinical trial NCT06544564 about?

NCT06544564 is a clinical study titled "Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population". This study is designed to assess the clinical effectiveness of Membrane Wrap, a human amniotic membrane for the management of difficult to heal partial- or full-thickness venous leg ulcers (VLUs)

What is the current status of trial NCT06544564?

This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2025-03-31. Estimated completion is 2026-09-30.

What conditions does trial NCT06544564 study?

This clinical trial studies the following conditions: Venous Leg Ulcer.

What interventions are being tested in trial NCT06544564?

The interventions under investigation include: Standard of Care (OTHER), Membrane Wrap™ (DEVICE).

Who is sponsoring clinical trial NCT06544564?

This trial is sponsored by BioLab Holdings, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06544564 being conducted?

This trial has 9 study locations across Arizona, California, Florida, Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Leg Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.